Success Story: Fast-Track NIW Success! Senior Research Technologist Approved in 25 Days Thanks to Our Expert Filing and Premium Processing

Client’s Testimonial:

“Thank you so much!!!! I can’t believe how quickly this got approved. Can’t thank you enough.”

On March 11^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Senior Research Technologist in the Field of Liver Disease (Approval Notice).

General Field: Liver Disease

Position at the Time of Case Filing: Senior Research Technologist

Country of Origin: Sri Lanka

State of Residence at the Time of Filing: Minnesota

Approval Notice Date: March 11^th, 2025

Processing Time: 25 days (Premium Processing Requested)

Case Summary:

We are proud to announce the approval of an I-140 NIW (National Interest Waiver) petition for a promising early-career researcher whose work is transforming the fight against liver cancer. This approval marks a significant milestone in the client’s efforts to continue pioneering research on improving outcomes for patients with intrahepatic cholangiocarcinoma.

Our client’s approach holds promise in unveiling new molecular mechanisms for combating one of the most aggressive forms of liver cancer. Her work is designed to enhance treatment options and offer hope to patients who currently face limited clinical outcomes and survival prospects.

The client is currently employed in a research-focused role where she is actively designing and conducting both in vitro and in vivo studies. Her ongoing research contributes directly to the development of targeted virotherapies and is disseminated through peer-reviewed publications and scientific presentations, solidifying her place at the forefront of translational liver cancer research.

To support the petition under the EB-2 NIW category, her record included:

● 2 peer-reviewed journal articles and 5 scientific abstracts,

● A total of 31 citations to date, demonstrating growing academic influence,

● Research published in top-tier journals, including a paper ranked among the top 10% most-cited in Molecular Biology & Genetics for its publication year,

● Funding from the National Institutes of Health (NIH), affirming the national relevance of her scientific contributions.

Her published work has provided new insight into molecular processes such as SAMe-sensitive LARP1 phosphorylation in liver cancer progression and AKAP12 phosphorylation in liver fibrosis, and has been cited by researchers exploring everything from hepatocellular carcinoma signaling to fibrosis regulation in liver disease.

To further substantiate her qualifications and impact, four expert letters of recommendation (3 independent letters and 1 dependent letter) were submitted, including one from an independent source.

“All of this shows that [Client] is a highly prominent researcher in liver disease who is mitigating the progression of liver diseases and contributing to the development of more effective therapeutic strategies. As [Client’s] findings play a critical role in guiding the development of more efficient treatments, it is clear that they are of great value to the field and that she is an irreplaceable presence in the research sphere.”

We congratulate this client on her well-deserved NIW approval. With the guidance and support of NAILG, we are excited to witness the future advancements she will make in cancer treatment and public health outcomes in the United States.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.